<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02437448</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-Nr. 2014-0573</org_study_id>
    <nct_id>NCT02437448</nct_id>
  </id_info>
  <brief_title>Breath Analysis in Lung Fibrosis</brief_title>
  <official_title>Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry (SESI-MS) in Patients With Pulmonary Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss Federal Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Swiss National Science Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to answer the question whether a disease specific profile of breath
      in patients with idiopathic lung fibrosis can be detected by an untargeted metabolomic study
      using exhaled breath analysis by mass spectrometry.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>IPF-specific mass spectrometric profile of volatile organic compounds of exhaled breath analysis (markers of IPF in exhaled breath)</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Idiopathic Lung Fibrosis</condition>
  <condition>Idiopathic Pulmonary Fibrosis</condition>
  <arm_group>
    <arm_group_label>Idiopathic lung fibrosis</arm_group_label>
    <description>20 IPF patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>20 subjects with no apparent lung disease and normal lung function testing. Matched for gender, age and smoking history.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>Idiopathic lung fibrosis</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Exhaled breath
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Confirmed diagnosis of idiopathic pulmonary fibrosis based on clinical, radiologic and/or
        pathologic data without evidence or suspicion of an alternative diagnosis that may
        contribute to their interstitial lung disease. Patients must fulfill all of the following
        criteria:
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Clinical symptoms consistent with IPF

          2. Age 40 through 80 years

          3. Diagnosis of UIP or IPF by HRCT and surgical lung biopsy as outlined in table 1. Only
             patients fulfilling the category &quot;YES&quot; will be included in the study.

          4. Extent of fibrotic changes (honeycombing, reticular changes) greater than extent of
             emphysema on HRCT scan

          5. No features supporting an alternative diagnosis

        Exclusion Criteria:

          1. Acute exacerbation within the last 6 weeks.

          2. Any relevant lung disease other than pulmonary fibrosis.

          3. Acute inflammatory disease (e.g. common cold) within the last 6 weeks.

          4. Acute or chronic hepatic disease.

          5. Renal failure or renal replacement therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Malcolm Kohler</last_name>
    <phone>+41 255 38 28</phone>
    <email>malcolm.kohler@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pulmonary Division, University Hospital of Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malcolm Kohler, MD</last_name>
      <phone>0041 44 255 97 51</phone>
      <email>Malcolm.Kohler@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Yvonne Nussbaumer, MD</last_name>
      <phone>0041 44 255 38 28</phone>
      <email>yvonne.nussbaumer@usz.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Malcolm Kohler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renato Zenobi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2015</study_first_submitted>
  <study_first_submitted_qc>May 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2015</study_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Malcolm Kohler</investigator_full_name>
    <investigator_title>Prof</investigator_title>
  </responsible_party>
  <keyword>Mass spectrometry</keyword>
  <keyword>Exhaled breath analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

